What Criticare Technologies does

Criticare Technologies, Inc. (CTI), originally founded as Criticare Systems Inc. in 1984, is a privately held international medical device company headquartered in Warwick, Rhode Island. The company designs, manufactures, and distributes patient monitoring devices and vital signs monitors that incorporate pulse oximetry, non-invasive blood pressure (NIBP), capnography, and anesthetic gas analysis technologies. Its product portfolio includes the nGenuity 8100E Series patient monitors, the eQuality 506DNB and VitalCare 506N3 Series vital signs monitors, the Poet IQ 8500H and nCompass 8100H monitors, the VitalView central station, and the Criticare Connect wireless connectivity module. The company holds a portfolio of granted patents and trademarks including ComfortCuff NIBP, DOX digital oximetry, SEQUEL pulse oximetry, High IQ far-infrared anesthetic gas monitoring, WaterChek water separation, UltraSync ECG synchronization, and reusable immersable SpO2 sensors, several of which are described as industry firsts.

Criticare generates revenue primarily through hardware sales of patient monitoring devices and accessory/consumable sales (SpO2 sensors, NIBP cuffs, ECG cables, water traps, sample lines, temperature probes, and calibration gases), supplemented by a service and repair operation based in Orlando, FL. Pricing is quote-based for medical devices, with an e-commerce storefront for accessories at criticare.com/shop. The company employs a hybrid go-to-market model combining direct enterprise sales, a global distributor network with a dedicated distributor resources page, and direct-to-customer e-commerce, and offers its monitors with optional Nellcor OxiMax pulse oximetry as an alternative to its proprietary DOX platform. It maintains an India corporate presence operated through Opto Circuits (I) Ltd. in Bengaluru, in addition to its US headquarters.

The company serves hospitals and healthcare facilities as its primary customer segment, with secondary segments in dental and oral surgery practices and outpatient/ambulatory settings. Use cases span anesthesia administration, critical care, respiratory care, conscious sedation, patient transport, and post-procedure recovery. Criticare holds ISO 13485 certification for medical device quality management and offers EMR/HIS integration across its VitalCare, nGenuity, and VitalView product lines via the Criticare Connect Bluetooth module and compatibility with multiple office management software platforms. Ownership structure, financial performance, and revenue figures are not publicly disclosed, and no venture or private equity funding rounds, M&A transactions, or leadership changes appear in the available source material.

Name

Criticare Technologies

Legal name

Criticare Systems Inc.

Website

https://criticare.com

Company type

Private

Founded year

1984

Operating status

Operating

Headcount range

101–250 employees

Short description

Criticare Technologies is a private medical device company founded in 1984 and headquartered in Warwick, RI, that designs, manufactures, and distributes patient monitoring devices and vital signs monitors. Its products serve hospitals, dental and oral surgery practices, and outpatient care facilities globally.

Ownership category

akta.pro rank

Product category

Medical Devices (Patient Monitoring)

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Vital Signs Monitoring (Multi-parameter, Spot-Check & Continuous) (HLAHACAA)

akta.pro secondary industry

Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI)

Keywords

• Patient monitoring devices
• Vital signs monitors
• Anesthetic gas monitoring
• Pulse oximetry systems
• Medical device manufacturing

Headquarters

HQ city

North Kingstown

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales: Sale of patient monitoring devices, vital signs monitors, and patient monitors including the nGenuity, eQuality, and VitalCare product lines
2. Accessories and Consumables: Sales of accessories including SpO2 sensors, NIBP cuffs and hoses, ECG cables and electrodes, water traps, sample lines, temperature probes, printers, and calibration gases
3. Service and Repair: Factory service and repairs for customer equipment, with dedicated service department in Orlando, FL

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Criticare Technologies designs, manufactures, and distributes patient monitoring and vital signs medical devices for healthcare facilities worldwide. The portfolio spans multi-parameter patient monitors, spot-check vital signs monitors, pulse oximeters, capnographs, and anesthetic gas monitoring systems marketed under product families including nGenuity, eQuality, VitalCare, nCompass, Poet IQ, and VitalView. Devices are sold to hospitals, surgery centers, and clinics primarily through direct sales, an e-commerce storefront, and a global distributor network.

Product overview

Criticare Technologies is a medical device company offering a portfolio of patient monitoring devices and vital signs monitors. The core product line includes the nGenuity 8100E Series patient monitors for conscious sedation and recovery monitoring, the eQuality 506DNB and VitalCare 506N3 Series vital signs monitors for spot-check and continuous monitoring, the nCompass 8100H Series and Poet IQ 8500H patient monitors, and the VitalView central station. The company also offers the Criticare Connect wireless connectivity add-on for EMR integration. Products feature proprietary technologies including ComfortCuff NIBP for on-inflation blood pressure measurement, DOX digital pulse oximetry, SEQUEL pulse oximetry, CO2 monitoring with sidestream capnography, anesthetic gas analysis using far-infrared technology, and WaterChek water separation systems. The portfolio serves anesthesia, critical care, respiratory care, transport, and outpatient care environments.

Differentiator

Problem solved

Functional benefit

Brands

• nGenuity: Patient monitor series including 8100E Series with ECG, NIBP, SpO2, and optional CO2 monitoring
• eQuality
• VitalCare
• Criticare Connect
• Poet IQ
• nCompass

Products and services

• nGenuity Patient Monitor
• eQuality Patient Monitor
• VitalCare Vital Signs Monitor
• nCompass Monitor
• Poet IQ Anesthetic Gas Monitor
• VitalView Monitor
• Criticare Connect

Quantifiable outcome

• ComfortCuff reduces patient discomfort by measuring blood pressure on inflation rather than deflation, reducing time with high constriction pressure
• +1 more outcomes

Segments3 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration13 records

Feature8 records

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Philips (Patient Monitoring): Broad incumbent in connected patient monitoring and clinical informatics, with IntelliVue bedside monitors and enterprise software platforms — competes with Criticare in hospital and ambulatory deployments but as part of a much larger portfolio.
• GE HealthCare: Broad incumbent offering CARESCAPE bedside monitors, anesthesia delivery, and digital health — competes in the same end markets as Criticare but at enterprise scale and with deeper R&D and service resources.

Direct peers

• Edan Instruments: China-based competitor offering a full line of patient monitors, vital signs monitors, and pulse oximetry products that directly overlap with Criticare's nGenuity, VitalCare, and nCompass families across hospital and ambulatory care.
• Mindray: One of the largest global patient monitoring and vital signs monitoring vendors, with multi-parameter bedside monitors, spot-check devices, and anesthesia gas modules directly comparable to Criticare's nGenuity, eQuality, and Poet IQ product families.
• Masimo: Pulse oximetry and patient monitoring leader whose SET pulse oximetry competes directly with Criticare's DOX technology, and whose rainbow/multiparameter devices are a reference point for the category.
• Nonin Medical: Specialist in pulse oximetry and capnography with both spot-check and continuous-monitoring products overlapping Criticare's DOX/SEQUEL pulse oximetry and sidestream CO2 modules.
• Nihon Kohden: Japan-based global medical electronics company with a strong patient monitoring franchise (bedside monitors, telemetry, EEG) and vital signs devices that compete head-to-head with Criticare in hospitals and outpatient care.
• Spacelabs Healthcare (OSI Systems): Specialist in patient monitoring and clinical informatics, with bedside and ambulatory monitoring products and central station software that directly compete with Criticare's Poet IQ and VitalView offerings in anesthesia and critical care.
• Dräger: Specialist in anesthesia, critical care, and patient monitoring — directly competing in the operating room and ICU segments where Criticare's Poet IQ anesthetic gas monitoring and nGenuity sedation monitors are sold.

Emerging players

• Contec Medical Systems: China-based vendor of patient monitors, vital signs devices, and pulse oximetry products with growing international distribution — competes with Criticare primarily in cost-sensitive emerging-market and ambulatory segments.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/criticare-technologies

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Criticare Technologies